These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37473460)

  • 21. Generation of an induced pluripotent stem cell line from a patient with global development delay carrying DYRK1A mutation (c.1730T>A) and a gene correction isogenic iPSC line.
    Ma L; Wu Z; Tang Q; Ji X; Mei Y; Peng T; Xu Q; Zhou W; Xiong M
    Stem Cell Res; 2021 May; 53():102305. PubMed ID: 33813175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRIi019-A-6) model of human precocious osteoarthritis.
    Yammine KM; Mirda Abularach S; Sampurno L; Bateman JF; Lamandé SR; Shoulders MD
    Stem Cell Res; 2023 Mar; 67():103020. PubMed ID: 36682125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.
    Hosseini Far H; Patria YN; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 May; 37():101449. PubMed ID: 31075690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of an induced pluripotent stem cell line from an Alström Syndrome patient with ALMS1 mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line.
    Ji X; Tang Q; Tang C; Wu Z; Ma L; Guo X; Cheng G; Chen Y; Yang T; Xiong M; Zhou W
    Stem Cell Res; 2020 Dec; 49():102089. PubMed ID: 33264725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene.
    Gao X; Qiu SW; Wang WQ; Kang DY; Su N; Dai P; Yuan YY
    Stem Cell Res; 2021 May; 53():102271. PubMed ID: 33714068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
    Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of isogenic and homozygous MEN1 mutant cell lines from patient-derived iPSCs using CRISPR/Cas9.
    Even-Zohar N; Metin-Armagan D; Ben-Shlomo A; Sareen D; Melmed S
    Stem Cell Res; 2023 Jun; 69():103124. PubMed ID: 37209468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of human induced pluripotent stem cell line UGENTi001-A from a patient with Marfan syndrome carrying a heterozygous c.7754 T > C variant in FBN1 and the isogenic control UGENT001-A-1 using CRISPR/Cas9 editing.
    Aalders J; Léger L; Demolder A; Muiño Mosquera L; Coucke P; Menten B; De Backer J; van Hengel J
    Stem Cell Res; 2023 Mar; 67():103036. PubMed ID: 36724552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of an induced pluripotent stem cell line carrying biallelic deletions (SCTCi019-B) in ALDH7A1 using CRISPR/Cas9.
    Schuurmans IME; Wu KM; van Karnebeek CDM; Nadif Kasri N; Garanto A
    Stem Cell Res; 2023 Sep; 71():103173. PubMed ID: 37540965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying FLNC exon skipping variant.
    Ader F; Duboscq-Bidot L; Marteau S; Hamlin M; Richard P; Fontaine V; Villard E
    Stem Cell Res; 2022 Jan; 58():102616. PubMed ID: 34883448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DEEP PHENOTYPING AND FURTHER INSIGHTS INTO ITM2B-RELATED RETINAL DYSTROPHY.
    Nassisi M; Wohlschlegel J; Liu B; Letellier C; Michiels C; Aubois A; Mohand-Said S; Habas C; Sahel JA; Zeitz C; Audo I
    Retina; 2021 Apr; 41(4):872-881. PubMed ID: 32826790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A).
    Kayser A; Dittmann S; Hamidi J; Laufer SD; Krampe R; Mearini G; Hansen A; Schulze-Bahr E
    Stem Cell Res; 2024 Aug; 78():103446. PubMed ID: 38776645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A).
    Djemai M; Jauvin D; Poulin H; Chapotte-Baldacci CA; Chahine M
    Stem Cell Res; 2024 Mar; 75():103308. PubMed ID: 38232626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9.
    Pavlinov I; Farkhondeh A; Yang S; Xu M; Cheng YS; Beers J; Zou J; Liu C; Might M; Rodems S; Baumgärtel K; Zheng W
    Stem Cell Res; 2021 Oct; 56():102554. PubMed ID: 34619643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.
    Meraviglia V; Arendzen CH; Tok M; Freund C; Maione AS; Sommariva E; Bellin M
    Stem Cell Res; 2020 Jul; 46():101835. PubMed ID: 32485643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing.
    Nur Patria Y; Lilianty J; Elefanty AG; Stanley EG; Labonne T; Bateman JF; Lamandé SR
    Stem Cell Res; 2020 Jan; 42():101689. PubMed ID: 31884373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9.
    Vitale MR; Zöller JEM; Jansch C; Janz A; Edenhofer F; Klopocki E; van den Hove D; Vanmierlo T; Rivero O; Nadif Kasri N; Ziegler GC; Lesch KP
    Stem Cell Res; 2021 Mar; 51():102169. PubMed ID: 33486346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9 and
    Muto V; Benigni F; Magliocca V; Borghi R; Flex E; Pallottini V; Rosa A; Compagnucci C; Tartaglia M
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.
    Barbuti P; Antony P; Santos B; Massart F; Cruciani G; Dording C; Arias J; Schwamborn J; Krüger R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32927687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9.
    Fatima A; Schuster J; Akram T; Sobol M; Hoeber J; Dahl N
    Stem Cell Res; 2020 Apr; 44():101758. PubMed ID: 32203915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.